Single-Use Systems are being used for more than 85% of biopharmaceutical manufacturing and increasingly being adopted to manufacture commercial products. The use of disposable products offer advantages such as flexibility, reduced capital cost and reduced water use.
Ahead of the 2020 Disposable Solutions for Biomanufacturing Forum, Pharma IQ had the opportunity to speak with Tony Hitchcock, Technical Director, Cobra Biologics, on the best practices for scaling your manufacturing capabilities and achieving process excellence through disposable technologies. This infographic presents the results as a handy 5 top-tip guide.
Download the infographic on the right >>
Other key benefits to downloading the infographic:
- Understand the industrialisation of single use solutions: learnings, attention points and opportunities
- Gain an in-depth insight into the solutions that meet the technical requirements of vendors
- Identify supply chain requirements – what you need from potential suppliers and how you can develop agreements to achieve this
After 2018's success, and with heads and directors from Torque Therapeutics, Fujifilm, GSK, Janssen and Boehringer Ingelheim already confirmed to attend in 2019, the majority of our 2018 partners have already snapped up the sponsorship opportunities available.
There are still a small number of networking and thought leadership opportunities available, if you'd like to discuss these, please contact the team at email@example.com or on +44 (0) 20 7368 9300.
Alternatively, fill in the form below to view the current floorplan >>
In this benchmarking survey report Pharma IQ draws comparisons with previous survey conducted at the end of 2013. Find out what has changed in the industry, what to consider when choosing new suppliers, best way to tackle extactables & leachables and we compare different investment approaches.
As the biopharmaceutical industry's focus moves from a blockbuster sales model to more targeted therapeutics, the need to avoid costly investments in sizable stainless steel equipment is increasing.
The use of single-use bioprocessing equipment is making product manufacture increasingly efficient and frequently less costly, particularly for early stages such as R&D and clinical trials.
Download the PDF to continue reading
Based on the opinions of over 50 biopharma experts, we have put together this industry overview discussing the latest drivers and challenges for the single-use market. This infographic covers topics including investigating continuous bioprocessing, flexibility in single-use systems, and the need to seek new products from suppliers.
With the release of the PDA Technical report 66 in mind, the adoption of single use systems has been again moved to the top of discussions in biomanufacturing and extractables and leachables is proving to be one of the major stumbling blocks. Pharma IQ have put extractables and leachables under the microscope using sources from Pharma IQ and elsewhere to look at the inhibitors and the guidance in this area.
In today’s bioprocessing industry, there is a demand to cut manufacturing costs while maintaining product safety and quality; flexibility needs to be increased and time to market reduced. With insights from Dr Philipp Hess, Managing Partner at PHA and our recent industry survey, this infographic will cover the key elements of process optimisation and efficiency used in single-use technology solutions.
There are a number of important considerations that need to be made in order to maximise your chances of success in selling your solution. This handy guide provides an overview of the decision making process for solution adoption in single-use systems and the key steps that need to be taken to give your product the best chance of customer success.
This infographic includes information on:
- Identifying decision makers and the decision making unit
- Establishing the scale of implementation for your customer
- Preparing your data to ensure it will pass SOPs, QA and validation procedures